Home » Topics » Regulatory » Patents

Patents
RSS

Preparation and use of new CNS-active series reported by Pharmacia & Upjohn

Nov. 12, 1998

Compounds for influenza developed at Shionogi

Nov. 12, 1998

Patent covers selective COX-2 inhibitors for relieving pain, fever and inflammation

Nov. 12, 1998

NOS-inhibitory condensed piperidines disclosed by Ono

Nov. 12, 1998

Proton pump inhibitors in the pipeline at Yuhan

Nov. 11, 1998

Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders

Nov. 11, 1998

Pyridyl compounds claimed by Astra for the Rx of asthma and rhinitis

Nov. 11, 1998

Chugai describes inhibitors of iNOS, nNOS

Nov. 11, 1998

Selective inhibitors of vascular wall, microsomal ACAT developed at Kowa

Nov. 11, 1998

Pharmacia & Upjohn patents new agents for CNS and neurodegenerative disorders

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...